Pharmesis International Ltd. (BFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Pharmesis International Ltd. (Pharmesis) is a pharmaceutical company that carries out the research, development production, and commercialization of Western medicines and traditional Chinese medicines. The company provides formulated products such as anetholtrithione (ATT) for the treatment of illnesses related to the liver and gall bladder. It provides products such as kinna, longlife and health supplements. The company has production facilities in the cities of Chengdu and Guilin in the Sichuan Province. For research and development, it collaborates with research institutes in China to identify and develop new drugs. Pharmesis sells its products all over China through an established sales and marketing network. The company operates through two subsidiaries, Chengdu Kinna Pharmaceutical Co., Ltd and Sichuan Longlife Pharmaceutical Co., Ltd. Pharmesis is headquartered in Chengdu, Sichuan, China.
Pharmesis International Ltd. Key Recent Developments
Feb 27, 2015: Pharmesis Announces Full Yearly Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table Of Contents
Pharmesis International Ltd. (BFK) - Financial and Strategic SWOT Analysis Review Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Section 1 - About the Company 6 Pharmesis International Ltd. - Key Facts 6 Pharmesis International Ltd. - Key Employees 7 Pharmesis International Ltd. - Key Employee Biographies 8 Pharmesis International Ltd. - Major Products and Services 9 Pharmesis International Ltd. - History 10 Pharmesis International Ltd. - Company Statement 11 Pharmesis International Ltd. - Locations And Subsidiaries 13 Head Office 13 Other Locations and Subsidiaries 13 Section 2 - Company Analysis 14 Pharmesis International Ltd. - Business Description 14 Pharmesis International Ltd. - Corporate Strategy 15 Pharmesis International Ltd. - SWOT Analysis 16 SWOT Analysis - Overview 16 Pharmesis International Ltd. - Strengths 16 Strength - Extensive Product Offerings 16 Strength - Focused RandD Activities 16 Strength - Production Facilities 16 Pharmesis International Ltd. - Weaknesses 17 Weakness - Decline in Western drugs segment 17 Pharmesis International Ltd. - Opportunities 18 Opportunity - Chinese Pharmaceutical Market 18 Opportunity - Market Potential: HCV 18 Opportunity - Growing Aged Population in China 18 Pharmesis International Ltd. - Threats 19 Threat - Stringent Government Regulations 19 Threat - Intense Competition 19 Threat - Uncertain RandD Outcomes 19 Pharmesis International Ltd. - Key Competitors 20 Section 3 - Company Financial Ratios 21 Financial Ratios - Capital Market Ratios 21 Financial Ratios - Annual Ratios 22 Performance Chart 23 Financial Performance 23 Financial Ratios - Interim Ratios 24 Financial Ratios - Ratio Charts 25 Section 4 - Company's Recent Developments 26 Feb 27, 2015: Pharmesis Announces Full Yearly Results 26 Section 5 - Appendix 28 Methodology 28 Ratio Definitions 28 About GlobalData 32 Contact Us 32 Disclaimer 32
List of Tables Pharmesis International Ltd., Key Facts 6 Pharmesis International Ltd., Key Employees 7 Pharmesis International Ltd., Key Employee Biographies 8 Pharmesis International Ltd., Major Products and Services 9 Pharmesis International Ltd., History 10 Pharmesis International Ltd., Other Locations 13 Pharmesis International Ltd., Subsidiaries 13 Pharmesis International Ltd., Key Competitors 20 Pharmesis International Ltd., Ratios based on current share price 21 Pharmesis International Ltd., Annual Ratios 22 Pharmesis International Ltd., Interim Ratios 24 Currency Codes 28 Capital Market Ratios 28 Equity Ratios 29 Profitability Ratios 29 Cost Ratios 30 Liquidity Ratios 30 Leverage Ratios 31 Efficiency Ratios 31
List of Figures Pharmesis International Ltd., Performance Chart (2011 - 2015) 23 Pharmesis International Ltd., Ratio Charts 25